Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|March 3, 2022
Current Status of Autophagy Enhancers in Metabolic Disorders and Other DiseasesKihyoun Park, Myung-Shik LeeAutophagy|April 25, 2022
Essential role of lysosomal Ca2+-mediated TFEB activation in mitophagy and functional adaptation of pancreatic β-cells to metabolic stressKihyoun Park, Myung-Shik LeeMolecular Metabolism|September 11, 2019
β-cell autophagy: Mechanism and role in β-cell dysfunctionYong-Ho Lee, Jinyoung Kim, Kihyoun Park, et al.Experimental & Molecular Medicine|August 31, 2023
Pancreatic β-cell mitophagy as an adaptive response to metabolic stress and the underlying mechanism that involves lysosomal Ca2+ releaseSoo-Jin Oh, Kihyoun Park, Seong Keun Sonn, et al.Autophagy|October 10, 2022
Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunctionKihyoun Park, Seong Keun Sonn, Seungwoon Seo, et al.Frontiers in Immunology|February 19, 2024
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced goutKihyoun Park, Injae Shin, Yoonseon Kim, et al.Cellular and Molecular Gastroenterology and Hepatology|April 17, 2026
Microbial monotherapy with Leuconostoc sp. LB-P8 improves inflammation and fibrosis in mouse primary sclerosing cholangitis by inhibiting TGFβ/SMAD signalingKihyoun Park, Joon Yong Kim, Seong Woon Roh, et al.Nature Communications|March 15, 2022
Lysosomal Ca2+-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stressKihyoun Park, Hyejin Lim, Jinyoung Kim, et al.Nature Communications|April 14, 2018
A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetesHyejin Lim, Yu-Mi Lim, Kook Hwan Kim, et al.Plos One|November 7, 2017
Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitisJune-Chul Lee, Hae-Youn Lee, Tae Kang Kim, et al.Pageof 2